Results 121 to 130 of about 64,045 (256)

Transcriptional repression by a secondary DNA binding surface of DNA topoisomerase I safeguards against hypertranscription. [PDF]

open access: yesNat Commun, 2023
Lau MS   +11 more
europepmc   +1 more source

Phenotypic Florfenicol Resistance in floR‐Harbouring Flavobacterium psychrophilum Isolates (CC‐ST90): A Case Study From Danish Freshwater Rainbow Trout Aquaculture

open access: yesJournal of Fish Diseases, Volume 49, Issue 12, December 2026.
ABSTRACT Monitoring antimicrobial resistance (AMR) in fish pathogens is essential for supporting sustainable aquaculture. In this study, susceptibility testing and genome sequencing were used to characterize the AMR profile of seven Flavobacterium psychrophilum originating from Danish rainbow trout farms (2019–2022).
Valentina L. Donati, Lone Madsen
wiley   +1 more source

Diphenyl ditelluride anticancer activity and DNA topoisomerase I poisoning in human colon cancer HCT116 cells. [PDF]

open access: yesOncotarget, 2023
Juchem ALM   +9 more
europepmc   +1 more source

Expression of Topoisomerase II Alpha in Canine Colorectal Polyps, Adenomas and Adenocarcinomas

open access: yesVeterinary and Comparative Oncology, Volume 24, Issue 4, Page 781-789, December 2026.
ABSTRACT With the development and increased accessibility of diagnostic methods in veterinary medicine, the possibilities for early detection of proliferative lesions in the canine large intestine have expanded over the past decade. Since in human medicine, topoisomerase II alpha (Topo IIα) is considered a prognostic and predictive marker in various ...
Joanna Fiedorowicz   +3 more
wiley   +1 more source

Patulin and Xestoquinol are inhibitors of DNA topoisomerase 1. [PDF]

open access: yesProc Natl Acad Sci U S A
Tumini E   +10 more
europepmc   +1 more source

Molecular Dynamics Investigations of Human DNA-Topoisomerase I Interacting with Novel Dewar Valence Photo-Adducts: Insights into Inhibitory Activity. [PDF]

open access: yesInt J Mol Sci, 2023
Di Martino J   +9 more
europepmc   +1 more source

Cotargeting DNA topoisomerase II enhances efficacy of RAS-targeted therapy in KRAS-mutant cancer models. [PDF]

open access: yesJ Clin Invest
Xu R   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy